United Kingdom· GB-APID-39274011000001100
Ibrance 125mg tablets
A palbociclib product containing palbociclib, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Palbociclib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EF01 (palbociclib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Palbociclib · ATC L01EF01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of palbociclib costs, country by country.
Normalised to the WHO defined daily dose (94 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Palbociclib · price per daily dose (94 mg)
USD · FX 28 Sept 2026
- CH Switzerland$155.65
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Palbociclib
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EF01
- ATC class
- Palbociclib
- Defined daily dose
- 94 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5415062353721
- gtin5415062353608
- gtin5415062353776
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
340 interactions on record for palbociclib.
Graded by severity as the source publishes them — 74 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Palbociclib · interactions on record
340 records
- 74 severe
- 256 moderate
- 10 minor
Most severe, free to view
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- ConivaptanC03XA02severe
- KetoconazoleH02CA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Palbociclib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaIBRANCEPFIZER CANADA ULC
- SwedenBrancen 100 mg Filmdragerad tablettAdalvo Limited
- CzechiaIBRANCEPfizer Europe MA EEIG, Bruxelles
- NetherlandsIbaclib 100 mg, filmomhulde tablettenElpen Pharmaceutical Co. Inc.
- United StatesIbrancePfizer Laboratories Div Pfizer Inc
- FinlandIBRANCEOrifarm Oy
- PolandIbrancePfizer Europe MA EEIG
- BelgiumIbrance 100 mgPfizer Europe MA
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ibrammaclib
- Bulgaria · Palbociclib
- Denmark · Palbociclib Newbury
- Estonia · Palbociclib
- Finland · Palbociclib Avansor
- Greece · Palbociclib Faran
- Croatia · Palbociclib
- Hungary · Palbociclib
- Iceland · Ibrance, Palbociclib Viatris
- Liechtenstein · Ibrance, Palbociclib Viatris
- Malta · Palbociclib, Palbociclib Lotus
- Netherlands · Ibaclib, Palbociclib Elpen
- Norway · Ibrance, Palbociclib Newbury
- Poland · Palbociclib Polpharma
- Sweden · Brancen, Brical
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d446c860-6c53-4c9d-9498-d0bc4b27f300 GET /v1/drugs/d446c860-6c53-4c9d-9498-d0bc4b27f300?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39274011000001100",
"desc": "Ibrance 125mg tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "39343811000001100",
"source": "dmd",
"vtm_id": "777047009",
"strength": "125 mg",
"substance": "Palbociclib",
"ingredient": "Palbociclib",
"supplier_code": "2082201000001106"
}See everything about palbociclib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.